Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy

Clinical trial NCT06850454 · RECRUITING

Trial details

NCT number: NCT06850454
Sponsor: Mahidol University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy Induced Nausea and Vomiting

Start date: 2025-01-10
Primary completion: 2026-01-10
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.